Document is current
Any future updates will be listed below
-
Authors
Saia, Francesco
Lauck, Sandra
Durand, Eric
Muir, Douglas F.
Spence, Mark
Vasa-Nicotera, Mariuca
Wood, David
Urbano-Carrillo, Cristóbal A.
Bouchayer, Damien
Iliescu, Vlad Anton
Etienne, Christophe Saint
Leclercq, Florence
Auffret, Vincent
Asmarats, Lluis
Di Mario, Carlo
Veugeois, Aurelie
Maly, Jiri
Schober, Andreas
Nombela-Franco, Luis
Werner, Nikos
Gómez-Hospital, Joan Antoni
Mascherbauer, Julia
Musumeci, Giuseppe
Meneveau, Nicolas
Meurice, Thibaud
Mahfoud, Felix
De Marco, Federico
Seidler, Tim
Leuschner, Florian
Joly, Patrick
Collet, Jean Philippe
Vogt, Ferdinand
Di Lorenzo, Emilio
Kuhn, Elmar
Disdier, Vicente Peral
McCalmont, Gemma
Rakova, Radka
Wesselink, Wilbert
Kurucova, Jana
Hachaturyan, Violetta
Lüske, Claudia M.
Bramlage, Peter https://orcid.org/0000-0003-4970-2110
Frank, Derk
,
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04579445 at ClinicalTrials.govDocuments that mention this clinical trial
The implementation of a streamlined TAVI patient pathway across five European countries: BENCHMARK registry
https://doi.org/10.1007/s00392-025-02638-z
-
Funding
Funding for this research was provided by:
Edwards Lifesciences
Universitätsklinikum Schleswig-Holstein - Campus Kiel
- License Information
-
More Information
Article History
Received: 30 July 2024
Accepted: 14 March 2025
First Online: 22 April 2025
Declarations
:
: FS received payment for lectures/presentations from Edwards Lifesciences, Medtronic, and Abbott and is on the Data Safety Monitoring Board/Advisory Board of Edwards Lifesciences. SL received consulting fees and support for attending meetings from Edwards Lifesciences and Medtronic. ED received consulting fees from Edwards Lifesciences. DFM received support for the present manuscript, consulting fees, payment for lectures/presentations, and support for attending meetings from Edwards Lifesciences. DF received consulting fees from Edwards Lifesciences. CAUC received consulting fees from Edwards Lifesciences, payment for lectures/presentations from Medtronic and Biotronik, and is on the Data Safety Monitoring Board/Advisory Board of Medtronik. CSE received consulting fees from Medtronic, Edwards Lifesciences, and Abbott. VA received consulting fees from Boston Scientific and payment for lectures/presentations from Edwards Lifesciences, Medtronic, and Abbott. LA received speaker feeds from Edwards Lifesciences. JM received grants, consulting fees, and payment/honoraria for lectures/presentations from Edwards Lifesciences, payment for lectures/presentations from St. Jude Medical Coordination Center BVBA (Abbott), and stock on Leviticus Cardio Ltd. AS received grant from Edwards Lifesciences. LNF received consulting fees from Edwards Lifesciences and Abbott Vascular. NW received grant from Shockwave Medical and Abiomed, support for attending meetings from Edwards Lifesciences, Medtronic, and Boston, and is on the Data Safety Monitoring Board/Advisory Board of the Cingular Study. JM (Julia Mascherbauer) received grants and support for attending meetings from Boston Scientific, Medtronic, Edwards Lifesciences, grant from Abbott, payment for lectures/presentations from Edwards Lifesciences and AOP, is on Data Safety Monitoring Board/Advisory Board of Amgen, and is ESC Nominating Committee Member 2022–2024. GMC received honoraria for consultancy for the present manuscript, educational grant, consulting fees, and payment for lectures/presentations from Edwards Lifesciences and is now an employee of Edwards Lifesciences. JK, WW, and RR are employees of Edwards Lifesciences. PB is representing the sponsor IPPMed who received funding from Edwards Lifesciences for performing the study. VH and CL are employees of IPPMed. DF received support for the present manuscript, payment for lectures/presentations, and support for attending meetings from Edwards Lifesciences. All other authors represent centres who received compensation from Edwards Lifesciences for the documentation of patients.
: The registry was approved by the independent ethics review boards at each participating site and all patients provided written informed consent.
